Inotiv, Inc. Overview
Pro stress-test →Inotiv is a contract research organization focused on nonclinical and analytical drug discovery and development services and research models and related products and services. The company operates through two principal segments serving pharmaceutical and medical device industries globally, with particular strength in preclinical research solutions.
Strategic Profile
Pro stress-test →Growth in global R&D spending and greater outsourcing by biopharma are fueling rising demand for Inotiv's expanded preclinical CRO services, with operational efficiencies, strategic acquisitions, and focus on animal welfare and accreditation driving margin stability and long-term earnings growth. Recent strategic initiatives include integrating LifeNet Health's TruVivo® platform into its Discovery and Translational Sciences business, using primary human hepatocytes to build physiologically relevant in vitro models that align preclinical models with human biology.
Competitive Landscape
Pro stress-test →Main competitors include Charles River Laboratories International, Thermo Fisher Scientific, WuXi AppTec, and Myriad Genetics. Inotiv competes as a specialized preclinical CRO with differentiated offerings in research models and discovery services, positioning itself as a more focused alternative to larger integrated life sciences companies.
Industry Context
Inotiv, Inc. operates in Contract Research Organization (CRO) / Preclinical Drug Discovery Services.
Key facts
Founded: 1974 · Headquarters: West Lafayette, Indiana · Revenue: $513.0M · Market cap: $38M